Balancing protection of public health and safety with the free movement of goods in the EU medical device sector

The case of ‘borderline products’ classification

Tasoula Tseliou

    Research output: Working paperDiscussion paperOther research output

    Abstract

    In 2013, the CJEU ruled on the ‘Lyocentre’ case touching upon an important and contemporary issue in the EU Medical Device regime – the classification issue between medical devices and medicinal products. This problem is connected with the internal market v. protection of health dilemma as well as the choice between minimum and maximum harmonization. The Commission aspires to solve the above dilemma by going towards maximum harmonization in this area in the form of a proposal for a new Regulation on medical devices. My hypothesis is that the new regulatory framework may be able to better balance these objectives and also deal with several problematic issues of the medical device regime. However, it is not likely to solve the problem of borderline products. In order to check that, I will explore harmonization and internal market law literature as well as the relevant case law. My argument is that because classification of borderline products is strongly related to technology and medical science, which are constantly changing, a strict and inflexible regulatory framework cannot abide by their fast pace. I conclude that this problem cannot be fully eliminated, but it can be improved through soft law instruments, as they can be easily adapted to change.
    Original languageEnglish
    Number of pages33
    Publication statusPublished - 2015

    Publication series

    NameTILEC Discussion Paper
    Volume2015-008

    Fingerprint

    freight traffic
    harmonization
    public health
    EU
    regime
    Law
    market
    case law
    regulation
    science
    health

    Keywords

    • medical device
    • borderline product
    • internal market
    • harmonization
    • public health
    • free movement of goods
    • medicinal product

    Cite this

    @techreport{57d2274706854ad1954e995a4cb4bf79,
    title = "Balancing protection of public health and safety with the free movement of goods in the EU medical device sector: The case of ‘borderline products’ classification",
    abstract = "In 2013, the CJEU ruled on the ‘Lyocentre’ case touching upon an important and contemporary issue in the EU Medical Device regime – the classification issue between medical devices and medicinal products. This problem is connected with the internal market v. protection of health dilemma as well as the choice between minimum and maximum harmonization. The Commission aspires to solve the above dilemma by going towards maximum harmonization in this area in the form of a proposal for a new Regulation on medical devices. My hypothesis is that the new regulatory framework may be able to better balance these objectives and also deal with several problematic issues of the medical device regime. However, it is not likely to solve the problem of borderline products. In order to check that, I will explore harmonization and internal market law literature as well as the relevant case law. My argument is that because classification of borderline products is strongly related to technology and medical science, which are constantly changing, a strict and inflexible regulatory framework cannot abide by their fast pace. I conclude that this problem cannot be fully eliminated, but it can be improved through soft law instruments, as they can be easily adapted to change.",
    keywords = "medical device, borderline product, internal market, harmonization, public health, free movement of goods, medicinal product",
    author = "Tasoula Tseliou",
    year = "2015",
    language = "English",
    series = "TILEC Discussion Paper",
    type = "WorkingPaper",

    }

    Balancing protection of public health and safety with the free movement of goods in the EU medical device sector : The case of ‘borderline products’ classification. / Tseliou, Tasoula.

    2015. (TILEC Discussion Paper; Vol. 2015-008).

    Research output: Working paperDiscussion paperOther research output

    TY - UNPB

    T1 - Balancing protection of public health and safety with the free movement of goods in the EU medical device sector

    T2 - The case of ‘borderline products’ classification

    AU - Tseliou, Tasoula

    PY - 2015

    Y1 - 2015

    N2 - In 2013, the CJEU ruled on the ‘Lyocentre’ case touching upon an important and contemporary issue in the EU Medical Device regime – the classification issue between medical devices and medicinal products. This problem is connected with the internal market v. protection of health dilemma as well as the choice between minimum and maximum harmonization. The Commission aspires to solve the above dilemma by going towards maximum harmonization in this area in the form of a proposal for a new Regulation on medical devices. My hypothesis is that the new regulatory framework may be able to better balance these objectives and also deal with several problematic issues of the medical device regime. However, it is not likely to solve the problem of borderline products. In order to check that, I will explore harmonization and internal market law literature as well as the relevant case law. My argument is that because classification of borderline products is strongly related to technology and medical science, which are constantly changing, a strict and inflexible regulatory framework cannot abide by their fast pace. I conclude that this problem cannot be fully eliminated, but it can be improved through soft law instruments, as they can be easily adapted to change.

    AB - In 2013, the CJEU ruled on the ‘Lyocentre’ case touching upon an important and contemporary issue in the EU Medical Device regime – the classification issue between medical devices and medicinal products. This problem is connected with the internal market v. protection of health dilemma as well as the choice between minimum and maximum harmonization. The Commission aspires to solve the above dilemma by going towards maximum harmonization in this area in the form of a proposal for a new Regulation on medical devices. My hypothesis is that the new regulatory framework may be able to better balance these objectives and also deal with several problematic issues of the medical device regime. However, it is not likely to solve the problem of borderline products. In order to check that, I will explore harmonization and internal market law literature as well as the relevant case law. My argument is that because classification of borderline products is strongly related to technology and medical science, which are constantly changing, a strict and inflexible regulatory framework cannot abide by their fast pace. I conclude that this problem cannot be fully eliminated, but it can be improved through soft law instruments, as they can be easily adapted to change.

    KW - medical device

    KW - borderline product

    KW - internal market

    KW - harmonization

    KW - public health

    KW - free movement of goods

    KW - medicinal product

    M3 - Discussion paper

    T3 - TILEC Discussion Paper

    BT - Balancing protection of public health and safety with the free movement of goods in the EU medical device sector

    ER -